192 related articles for article (PubMed ID: 18754862)
1. Roles of the histone acetyltransferase monocytic leukemia zinc finger protein in normal and malignant hematopoiesis.
Katsumoto T; Yoshida N; Kitabayashi I
Cancer Sci; 2008 Aug; 99(8):1523-7. PubMed ID: 18754862
[TBL] [Abstract][Full Text] [Related]
2. MOZ is essential for maintenance of hematopoietic stem cells.
Katsumoto T; Aikawa Y; Iwama A; Ueda S; Ichikawa H; Ochiya T; Kitabayashi I
Genes Dev; 2006 May; 20(10):1321-30. PubMed ID: 16702405
[TBL] [Abstract][Full Text] [Related]
3. The monocytic leukemia zinc finger protein MOZ is a histone acetyltransferase.
Champagne N; Pelletier N; Yang XJ
Oncogene; 2001 Jan; 20(3):404-9. PubMed ID: 11313971
[TBL] [Abstract][Full Text] [Related]
4. The role of MOZ/KAT6A in hematological malignancies and advances in MOZ/KAT6A inhibitors.
Su J; Wang X; Bai Y; Sun M; Yao Y; Duan Y
Pharmacol Res; 2021 Dec; 174():105930. PubMed ID: 34626770
[TBL] [Abstract][Full Text] [Related]
5. MOZ and MORF, two large MYSTic HATs in normal and cancer stem cells.
Yang XJ; Ullah M
Oncogene; 2007 Aug; 26(37):5408-19. PubMed ID: 17694082
[TBL] [Abstract][Full Text] [Related]
6. The histone acetyl transferase activity of monocytic leukemia zinc finger is critical for the proliferation of hematopoietic precursors.
Perez-Campo FM; Borrow J; Kouskoff V; Lacaud G
Blood; 2009 May; 113(20):4866-74. PubMed ID: 19264921
[TBL] [Abstract][Full Text] [Related]
7. MOZ-TIF2 repression of nuclear receptor-mediated transcription requires multiple domains in MOZ and in the CID domain of TIF2.
Yin H; Glass J; Blanchard KL
Mol Cancer; 2007 Aug; 6():51. PubMed ID: 17697320
[TBL] [Abstract][Full Text] [Related]
8. Symplekin, a polyadenylation factor, prevents MOZ and MLL activity on HOXA9 in hematopoietic cells.
Largeot A; Paggetti J; Broséus J; Aucagne R; Lagrange B; Martin RZ; Berthelet J; Quéré R; Lucchi G; Ducoroy P; Bastie JN; Delva L
Biochim Biophys Acta; 2013 Dec; 1833(12):3054-3063. PubMed ID: 23994619
[TBL] [Abstract][Full Text] [Related]
9. MOZ is critical for the development of MOZ/MLL fusion-induced leukemia through regulation of Hoxa9/Meis1 expression.
Katsumoto T; Ogawara Y; Yamagata K; Aikawa Y; Goitsuka R; Nakamura T; Kitabayashi I
Blood Adv; 2022 Oct; 6(19):5527-5537. PubMed ID: 35947126
[TBL] [Abstract][Full Text] [Related]
10. MOZ increases p53 acetylation and premature senescence through its complex formation with PML.
Rokudai S; Laptenko O; Arnal SM; Taya Y; Kitabayashi I; Prives C
Proc Natl Acad Sci U S A; 2013 Mar; 110(10):3895-900. PubMed ID: 23431171
[TBL] [Abstract][Full Text] [Related]
11. Rearrangement of the MOZ gene in pediatric therapy-related myelodysplastic syndrome with a novel chromosomal translocation t(2;8)(p23;p11).
Imamura T; Kakazu N; Hibi S; Morimoto A; Fukushima Y; Ijuin I; Hada S; Kitabayashi I; Abe T; Imashuku S
Genes Chromosomes Cancer; 2003 Apr; 36(4):413-9. PubMed ID: 12619166
[TBL] [Abstract][Full Text] [Related]
12. [FGFR1 and MOZ, two key genes involved in malignant hemopathies linked to rearrangements within the chromosomal region 8p11-12].
Pébusque MJ; Chaffanet M; Popovici C; Birnbaum D
Bull Cancer; 2000 Dec; 87(12):887-94. PubMed ID: 11174118
[TBL] [Abstract][Full Text] [Related]
13. MYST family histone acetyltransferases take center stage in stem cells and development.
Voss AK; Thomas T
Bioessays; 2009 Oct; 31(10):1050-61. PubMed ID: 19722182
[TBL] [Abstract][Full Text] [Related]
14. MOZ fusion proteins in acute myeloid leukaemia.
Troke PJ; Kindle KB; Collins HM; Heery DM
Biochem Soc Symp; 2006; (73):23-39. PubMed ID: 16626284
[TBL] [Abstract][Full Text] [Related]
15. Acute mixed lineage leukemia with an inv(8)(p11q13) resulting in fusion of the genes for MOZ and TIF2.
Liang J; Prouty L; Williams BJ; Dayton MA; Blanchard KL
Blood; 1998 Sep; 92(6):2118-22. PubMed ID: 9731070
[TBL] [Abstract][Full Text] [Related]
16. Fusion of MOZ and p300 histone acetyltransferases in acute monocytic leukemia with a t(8;22)(p11;q13) chromosome translocation.
Kitabayashi I; Aikawa Y; Yokoyama A; Hosoda F; Nagai M; Kakazu N; Abe T; Ohki M
Leukemia; 2001 Jan; 15(1):89-94. PubMed ID: 11243405
[TBL] [Abstract][Full Text] [Related]
17. Bromodomain-PHD finger protein 1 is critical for leukemogenesis associated with MOZ-TIF2 fusion.
Shima H; Yamagata K; Aikawa Y; Shino M; Koseki H; Shimada H; Kitabayashi I
Int J Hematol; 2014 Jan; 99(1):21-31. PubMed ID: 24258712
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk between leukemia-associated proteins MOZ and MLL regulates HOX gene expression in human cord blood CD34+ cells.
Paggetti J; Largeot A; Aucagne R; Jacquel A; Lagrange B; Yang XJ; Solary E; Bastie JN; Delva L
Oncogene; 2010 Sep; 29(36):5019-31. PubMed ID: 20581860
[TBL] [Abstract][Full Text] [Related]
19. MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP.
Deguchi K; Ayton PM; Carapeti M; Kutok JL; Snyder CS; Williams IR; Cross NC; Glass CK; Cleary ML; Gilliland DG
Cancer Cell; 2003 Mar; 3(3):259-71. PubMed ID: 12676584
[TBL] [Abstract][Full Text] [Related]
20. An efficient high-throughput screening method for MYST family acetyltransferases, a new class of epigenetic drug targets.
Falk H; Connor T; Yang H; Loft KJ; Alcindor JL; Nikolakopoulos G; Surjadi RN; Bentley JD; Hattarki MK; Dolezal O; Murphy JM; Monahan BJ; Peat TS; Thomas T; Baell JB; Parisot JP; Street IP
J Biomol Screen; 2011 Dec; 16(10):1196-205. PubMed ID: 22086725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
